vs

Side-by-side financial comparison of Health Catalyst, Inc. (HCAT) and SunPower Inc. (SPWR). Click either name above to swap in a different company.

SunPower Inc. is the larger business by last-quarter revenue ($79.7M vs $74.7M, roughly 1.1× Health Catalyst, Inc.). SunPower Inc. runs the higher net margin — -17.8% vs -121.9%, a 104.1% gap on every dollar of revenue. On growth, Health Catalyst, Inc. posted the faster year-over-year revenue change (-6.2% vs -10.1%). Over the past eight quarters, SunPower Inc.'s revenue compounded faster (118.7% CAGR vs -0.0%).

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

SunPower Corporation is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company, headquartered in San Jose, California, was founded in 1985 by Richard Swanson, an electrical engineering professor from Stanford University. Cypress Semiconductor bought a majority interest in the company in 2002, growing it quickly until SunPower went public in 2005. TotalEnergies, a French energy and oil company p...

HCAT vs SPWR — Head-to-Head

Bigger by revenue
SPWR
SPWR
1.1× larger
SPWR
$79.7M
$74.7M
HCAT
Growing faster (revenue YoY)
HCAT
HCAT
+3.9% gap
HCAT
-6.2%
-10.1%
SPWR
Higher net margin
SPWR
SPWR
104.1% more per $
SPWR
-17.8%
-121.9%
HCAT
Faster 2-yr revenue CAGR
SPWR
SPWR
Annualised
SPWR
118.7%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCAT
HCAT
SPWR
SPWR
Revenue
$74.7M
$79.7M
Net Profit
$-91.0M
$-14.2M
Gross Margin
35.5%
Operating Margin
-115.3%
-27.4%
Net Margin
-121.9%
-17.8%
Revenue YoY
-6.2%
-10.1%
Net Profit YoY
-340.3%
-130.1%
EPS (diluted)
$-1.29
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCAT
HCAT
SPWR
SPWR
Q4 25
$74.7M
$79.7M
Q3 25
$76.3M
$22.0M
Q2 25
$80.7M
$67.5M
Q1 25
$79.4M
$82.7M
Q4 24
$79.6M
$88.7M
Q3 24
$76.4M
Q2 24
$75.9M
Q1 24
$74.7M
Net Profit
HCAT
HCAT
SPWR
SPWR
Q4 25
$-91.0M
$-14.2M
Q3 25
$-22.2M
$-16.9M
Q2 25
$-41.0M
$-22.4M
Q1 25
$-23.7M
$8.1M
Q4 24
$-20.7M
$47.0M
Q3 24
$-14.7M
Q2 24
$-13.5M
Q1 24
$-20.6M
Gross Margin
HCAT
HCAT
SPWR
SPWR
Q4 25
35.5%
Q3 25
52.6%
Q2 25
42.6%
Q1 25
48.5%
Q4 24
46.5%
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
HCAT
HCAT
SPWR
SPWR
Q4 25
-115.3%
-27.4%
Q3 25
-22.9%
-15.7%
Q2 25
-46.0%
-4.0%
Q1 25
-25.4%
1.3%
Q4 24
-22.0%
-24.2%
Q3 24
-17.9%
Q2 24
-20.8%
Q1 24
-30.5%
Net Margin
HCAT
HCAT
SPWR
SPWR
Q4 25
-121.9%
-17.8%
Q3 25
-29.1%
-76.9%
Q2 25
-50.8%
-33.2%
Q1 25
-29.9%
9.8%
Q4 24
-26.0%
53.0%
Q3 24
-19.3%
Q2 24
-17.8%
Q1 24
-27.6%
EPS (diluted)
HCAT
HCAT
SPWR
SPWR
Q4 25
$-1.29
$-0.05
Q3 25
$-0.32
$-0.19
Q2 25
$-0.59
$-0.28
Q1 25
$-0.35
$0.00
Q4 24
$-0.33
$0.27
Q3 24
$-0.24
Q2 24
$-0.23
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCAT
HCAT
SPWR
SPWR
Cash + ST InvestmentsLiquidity on hand
$95.7M
$9.6M
Total DebtLower is stronger
$153.3M
$164.8M
Stockholders' EquityBook value
$245.8M
$-90.1M
Total Assets
$502.6M
$241.2M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCAT
HCAT
SPWR
SPWR
Q4 25
$95.7M
$9.6M
Q3 25
$91.5M
$5.1M
Q2 25
$97.3M
$11.1M
Q1 25
$342.0M
$10.6M
Q4 24
$392.0M
$13.4M
Q3 24
$387.3M
Q2 24
$308.3M
Q1 24
$327.8M
Total Debt
HCAT
HCAT
SPWR
SPWR
Q4 25
$153.3M
$164.8M
Q3 25
$153.1M
$204.3M
Q2 25
$153.0M
$152.9M
Q1 25
$382.9M
Q4 24
$382.4M
$147.3M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
HCAT
HCAT
SPWR
SPWR
Q4 25
$245.8M
$-90.1M
Q3 25
$331.9M
$-112.3M
Q2 25
$347.5M
$-107.2M
Q1 25
$376.8M
$-89.0M
Q4 24
$365.2M
$-97.5M
Q3 24
$355.0M
Q2 24
$357.0M
Q1 24
$357.2M
Total Assets
HCAT
HCAT
SPWR
SPWR
Q4 25
$502.6M
$241.2M
Q3 25
$587.1M
$208.3M
Q2 25
$616.2M
$163.1M
Q1 25
$891.5M
$147.8M
Q4 24
$858.9M
$144.5M
Q3 24
$813.0M
Q2 24
$691.7M
Q1 24
$695.1M
Debt / Equity
HCAT
HCAT
SPWR
SPWR
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCAT
HCAT
SPWR
SPWR
Operating Cash FlowLast quarter
$9.9M
$-1.9M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCAT
HCAT
SPWR
SPWR
Q4 25
$9.9M
$-1.9M
Q3 25
$-464.0K
$-6.4M
Q2 25
$-9.0M
$-4.4M
Q1 25
$280.0K
$-2.6M
Q4 24
$-3.5M
$-25.6M
Q3 24
$6.2M
Q2 24
$1.6M
Q1 24
$10.3M
Free Cash Flow
HCAT
HCAT
SPWR
SPWR
Q4 25
$9.6M
Q3 25
$-719.0K
Q2 25
$-9.2M
Q1 25
$-390.0K
Q4 24
$-3.9M
Q3 24
$5.5M
Q2 24
$1.3M
Q1 24
$10.1M
FCF Margin
HCAT
HCAT
SPWR
SPWR
Q4 25
12.9%
Q3 25
-0.9%
Q2 25
-11.4%
Q1 25
-0.5%
Q4 24
-4.9%
Q3 24
7.2%
Q2 24
1.7%
Q1 24
13.5%
Capex Intensity
HCAT
HCAT
SPWR
SPWR
Q4 25
0.4%
Q3 25
0.3%
Q2 25
0.3%
Q1 25
0.8%
Q4 24
0.5%
Q3 24
0.9%
Q2 24
0.4%
Q1 24
0.3%
Cash Conversion
HCAT
HCAT
SPWR
SPWR
Q4 25
Q3 25
Q2 25
Q1 25
-0.32×
Q4 24
-0.54×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

SPWR
SPWR

Residential Solar Installation$46.9M59%
New Homes Business$22.7M29%
Other$10.1M13%

Related Comparisons